Doctor Sues Merck Over Keytruda Dosage

A doctor, Daniel Goldstein, is suing Merck (MSD) over the dosage of the cancer drug Keytruda. Goldstein claims the drug is given in excessive amounts, while Merck is profiting billions. This dispute raises concerns about pharmaceutical practices and patient safety.

Summarized from the sources above. Read the originals for the full story.